Events and Conferences

Sponsored Webcast: Planning for a Successful Initial IND and Moving Beyond: Regulatory CMC Considerations for Biotherapeutics and Cell and Gene Therapies

Veristat and  CITELINE  hosted a  webinar on the topic: Single-Arm Studies for Use as a Registrational Study in Oncology                        

Veristat and  TOPRA hosted a webinar on the topic: Impact of New EU Regulations on the Development of Medical Devices and Drug Combination Products                             

Meet with Shaheen Limbada, EVP Innovation and Strategy at the Evolution Summit

Veristat’s John Balser, PhD., will be presenting in the scientific symposium  

Attend our Innovation Theater Presentation on Decentralized Clinical Trials

Veristat and TOPRA hosted  a new updated content webinar on the topic:  Future Trends on European Regulations on Medicines                            

What  You Will Learn

The European Commission announced on 25 November 2020 the adoption of the new Pharmaceutical Strategy for Europe. It is an approach intended to ensure strong, fair competitivity and green industry, fostering patient access to innovative and affordable medicines. It will ensure an autonomous and robust supply chain and a stronger EU voice at the global level by promoting a high level of quality, efficacy and safety standards. 

Meet Veristat thought leaders at this exclusive event

Share your experiences and learn from other

industry executives

Share your experiences and learn from other

industry executives